The NLP in Healthcare and Life Sciences Market Size was valued at USD 2.6 billion in 2023 and is expected to reach USD 27.84 billion by 2031, and grow at a CAGR of 34.5% over the forecast period 2024-2031.
The rising trend of implementing artificial intelligence in natural language processing in the healthcare industry, which helps healthcare specialists extract exact information from reliable sources in real-time, thereby assisting healthcare specialists in performing critical tasks, combined with the growing use of natural language processing for machine translation and information extraction, is fueling the growth of the NLP in healthcare and life sciences market.
Get more information on NLP In Healthcare And Life Sciences Market - Request Sample Report
By eliminating the language barrier, machine translation aids physicians inefficiently speaking with their patients, allowing them to clarify the patient's health past data, which they can then analyze for a clinical diagnosis or prescribe a treatment plan.
DRIVERS
The demand for analyzing and extracting insights from narrative text and vast amounts of healthcare data is growing.
RESTRAINTS
Inadequacies in neural network-based NLP technology limit its use for cloud-based services.
Highly expensive
Require huge investment
OPPORTUNITIES
The rise of cognitive computing is expected to increase the demand for NLP solutions for precision medicine.
Improvement in technologies
CHALLENGES
During COVID-19, researchers' work is slowed by increasing regulatory compliance and privacy worries about data security.
COVID-19 is causing havoc in the world, businesses, and economies, affecting people's lives, interactions, and the way they run their companies. As businesses turn their focus away from development prospects and toward implementing extraordinary steps to limit the impact of the COVID-19 pandemic, the ability to sustain has become the new normal. Pharmaceutical and healthcare organizations, governments, and the larger scientific community are all attempting to assess the virus's impact and provide speedy, precise treatments in the ongoing fight against COVID-19.
NLP technology, according to a few suppliers in the market, will enable fast, systematic, and complete insight production from unstructured text. Scientific literature, clinical trial records, preprints, internal sources, medical records, social media, and news reporting are all possible sources. Capturing crucial information from these various sources and combining it into a single Evidence Hub allows users to have a better understanding of the situation, resulting in faster results. NLP has been widely utilized in a variety of companies to identify feelings, make suggestions, summarize data, and model topics.
By Component:
Solution
Services
By Deployment Mode:
Cloud
On-premises
By Organization Size:
By NLP:
Rule-based
Hybrid
Statistical
By Application:
IVR
Summarization and Categorization
Pattern and Image Recognition
Predictive Risk Analytics
Text and Speech Analytics
Reporting and Visualization
Other
By End User:
NLP for Physician
NLP for Clinical Operators
NLP for Patients
NLP for Researchers
Need any customization research on NLP In Healthcare And Life Sciences Market - Enquiry Now
In the NLP in healthcare and life sciences industry, North America is predicted to have the greatest market share. The success of main suppliers in the market in North America is due to the early implementation of NLP solutions and quick improvements in IT infrastructure across healthcare sectors. Because of the favorable stance of government laws, startup funding, established player presence, and enthusiasm from enterprises to deploy ML and NLP-based solutions, the region has seen excellent conditions for the expansion of NLP in the healthcare and life sciences market.
REGIONAL COVERAGE:
North America
USA
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Rest of Europe
Asia-Pacific
Japan
south Korea
China
India
Australia
Rest of Asia-Pacific
The Middle East & Africa
Israel
UAE
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
There are some of the major key players are IBM, 3M, Health Fidelity, Inc., Linguamatics, Cerner Corporation, Dolbey, Apixio, Amazon.com, Microsoft Corporation, and other players.
Report Attributes | Details |
---|---|
Market Size in 2023 | US$ 2.6 Billion |
Market Size by 2031 | US$ 27.84 Billion |
CAGR | CAGR of 34.5% From 2024 to 2031 |
Base Year | 2023 |
Forecast Period | 2024-2031 |
Historical Data | 2020-2022 |
Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
Key Segments | • By Component Type (Solution, Services) • By Deployment Mode (Cloud, On-premises) • By Organization Size (Large enterprises, SMEs) • By NLP (Rule-based, Hybrid, Statistical) • By Application (IVR, Summarization and Categorization, Pattern and Image Recognition, Predictive Risk Analytics, Text and Speech Analytics, Reporting and Visualization, Other) • By End User (NLP for Physician, NLP for Clinical Operators, NLP for Patients, NLP for Researchers) |
Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
Company Profiles | IBM, 3M, Health Fidelity, Inc., Linguamatics, Cerner Corporation, Dolbey, Apixio, Amazon.com, Microsoft Corporation, and other players. |
DRIVERS | • The demand for analyzing and extracting insights from narrative text and vast amounts of healthcare data is growing. |
RESTRAINTS | • Inadequacies in neural network-based NLP technology limit its use for cloud-based services. • Highly expensive • Require huge investment |
Ans:- The NLP in Healthcare and Life Sciences Market size is to reach US$ 9.54 billion by 2030.
The main players in the NLP in Healthcare and Life Sciences market are IBM, 3M, Health Fidelity, Inc., Linguamatics, Cerner Corporation, Dolbey, Apixio, Amazon.com, Microsoft Corporation.
Solution and Services are the sub-segments of component type.
Ans:- The NLP In Healthcare And Life Sciences Market is to grow at a CAGR of 19.1% over the forecast period 2023-2030.
Highly expensive, and Requiring hug investment is the restraint of the NLP in Healthcare and Life Sciences
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.1 Introduction
4.3.2 Impact on major economies
4.3.2.1 US
4.3.2.2 Canada
4.3.2.3 Germany
4.3.2.4 France
4.3.2.5 United Kingdom
4.3.2.6 China
4.3.2.7 Japan
4.3.2.8 South Korea
4.3.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. NLP in Healthcare and Life Sciences Market Segmentation, by Component type
8.1 Solution
8.2 Services
9. NLP in Healthcare and Life Sciences Market Segmentation, by Deployment Mode type
9.1 Cloud
9.2 On-premises
10 NLP in Healthcare and Life Sciences Market Segmentation, By Organization Size type
10.1 Large enterprises
10.2 Small and medium-sized enterprises (SMEs)
11. NLP in Healthcare and Life Sciences Market Segmentation, By NLP Type
11.1 Rule-based
11.2 Hybrid
11.3 Statistical
12. NLP in Healthcare and Life Sciences Market Segmentation, End User
12.1 NLP for Physician
12.2 NLP for Clinical Operators
12.3 NLP for Patients
12.4 NLP for Researchers
13. Regional Analysis
13.1 Introduction
13.2 North America
13.2.1 USA
13.2.2 Canada
13.2.3 Mexico
13.3 Europe
13.3.1 Germany
13.3.2 UK
13.3.3 France
13.3.4 Italy
13.3.5 Spain
13.3.6 The Netherlands
13.3.7 Rest of Europe
13.4 Asia-Pacific
13.4.1 Japan
13.4.2 South Korea
13.4.3 China
13.4.4 India
13.4.5 Australia
13.4.6 Rest of Asia-Pacific
13.5 The Middle East & Africa
13.5.1 Israel
13.5.2 UAE
13.5.3 South Africa
13.5.4 Rest
13.6 Latin America
13.6.1 Brazil
13.6.2 Argentina
13.6.3 Rest of Latin America
14. Company Profiles
14.1 IBM
14.1.1 Financial
14.1.2 Products/ Services Offered
14.1.3 SWOT Analysis
14.1.4 The SNS view
14.2 3M Company
14.3 Health Fidelity, Inc.
14.4 Linguamatics
14.5 Cerner Corporation
14.6 Dolbey
14.7 Apixio
14.8 Amazon.com
14.9 Microsoft Corporation.
15. Competitive Landscape
15.1 Competitive Benchmark
15.2 Market Share Analysis
15.3 Recent Developments
16. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Risk-based Monitoring Software Market Size was valued at USD 359.32 Million in 2023, and is expected to reach USD 1004.32 Million by 2031, and grow at a CAGR of 13.71% over the forecast period 2024-2031.
The Hospital Capacity Management Solutions Market Size was valued at USD 4.17 billion in 2023 and expected to reach USD 14.85 billion by 2031 and grow at a CAGR of 17.2% over the forecast period 2024-2031.
The Diabetic Ulcer Treatment Market Size was valued at USD 4.12 billion in 2023, and is expected to reach USD 8.65 billion by 2032, and grow at a CAGR of 8.60% over the forecast period 2024-2032.
The Medical Tape and Bandage Market Size was valued at USD 7.80 Billion in 2023, and is expected to reach USD 11.10 Billion by 2032, and grow at a CAGR of 4.12%.
The Cosmeceuticals Market Size was valued at USD 63.63 Billion in 2023, and is expected to reach USD 142.52 Billion by 2032, and grow at a CAGR of 9.84%.
The Ureteroscope Market Size was valued at USD 1,056.2 Million in 2023 and is expected to reach USD 1,685.14 Million by 2032 and grow at a CAGR of 5.54% over the forecast period 2024-2032.
Hi! Click one of our member below to chat on Phone